Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Cholestenoic acids regulate motor neuron survival via liver X receptors
Spyridon Theofilopoulos, … , Ernest Arenas, Yuqin Wang
Spyridon Theofilopoulos, … , Ernest Arenas, Yuqin Wang
Published October 1, 2014
Citation Information: J Clin Invest. 2014;124(11):4829-4842. https://doi.org/10.1172/JCI68506.
View: Text | PDF
Research Article Neuroscience Article has an altmetric score of 30

Cholestenoic acids regulate motor neuron survival via liver X receptors

  • Text
  • PDF
Abstract

Cholestenoic acids are formed as intermediates in metabolism of cholesterol to bile acids, and the biosynthetic enzymes that generate cholestenoic acids are expressed in the mammalian CNS. Here, we evaluated the cholestenoic acid profile of mammalian cerebrospinal fluid (CSF) and determined that specific cholestenoic acids activate the liver X receptors (LXRs), enhance islet-1 expression in zebrafish, and increase the number of oculomotor neurons in the developing mouse in vitro and in vivo. While 3β,7α-dihydroxycholest-5-en-26-oic acid (3β,7α-diHCA) promoted motor neuron survival in an LXR-dependent manner, 3β-hydroxy-7-oxocholest-5-en-26-oic acid (3βH,7O-CA) promoted maturation of precursors into islet-1+ cells. Unlike 3β,7α-diHCA and 3βH,7O-CA, 3β-hydroxycholest-5-en-26-oic acid (3β-HCA) caused motor neuron cell loss in mice. Mutations in CYP7B1 or CYP27A1, which encode enzymes involved in cholestenoic acid metabolism, result in different neurological diseases, hereditary spastic paresis type 5 (SPG5) and cerebrotendinous xanthomatosis (CTX), respectively. SPG5 is characterized by spastic paresis, and similar symptoms may occur in CTX. Analysis of CSF and plasma from patients with SPG5 revealed an excess of the toxic LXR ligand, 3β-HCA, while patients with CTX and SPG5 exhibited low levels of the survival-promoting LXR ligand 3β,7α-diHCA. Moreover, 3β,7α-diHCA prevented the loss of motor neurons induced by 3β-HCA in the developing mouse midbrain in vivo.Our results indicate that specific cholestenoic acids selectively work on motor neurons, via LXR, to regulate the balance between survival and death.

Authors

Spyridon Theofilopoulos, William J. Griffiths, Peter J. Crick, Shanzheng Yang, Anna Meljon, Michael Ogundare, Satish Srinivas Kitambi, Andrew Lockhart, Karin Tuschl, Peter T. Clayton, Andrew A. Morris, Adelaida Martinez, M. Ashwin Reddy, Andrea Martinuzzi, Maria T. Bassi, Akira Honda, Tatsuki Mizuochi, Akihiko Kimura, Hiroshi Nittono, Giuseppe De Michele, Rosa Carbone, Chiara Criscuolo, Joyce L. Yau, Jonathan R. Seckl, Rebecca Schüle, Ludger Schöls, Andreas W. Sailer, Jens Kuhle, Matthew J. Fraidakis, Jan-Åke Gustafsson, Knut R. Steffensen, Ingemar Björkhem, Patrik Ernfors, Jan Sjövall, Ernest Arenas, Yuqin Wang

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Total
Citations: 1 8 1 8 5 11 1 6 7 6 1 55
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (55)

Title and authors Publication Year
Elevated Bile Acid 3β,5α,6β-Trihydroxycholanoyl Glycine in a Subset of Adult Ataxias Including Niemann–Pick Type C
Motamed-Gorji N, Khalil Y, Gonzalez-Robles C, Khan S, Mills P, Garcia-Moreno H, Ging H, Tariq A, Clayton PT, Giunti P
Antioxidants 2024
Amyotrophic lateral sclerosis: translating genetic discoveries into therapies.
Akçimen F, Lopez ER, Landers JE, Nath A, Chiò A, Chia R, Traynor BJ
Nature reviews. Genetics 2023
Chenodeoxycholic acid rescues axonal degeneration in induced pluripotent stem cell-derived neurons from spastic paraplegia type 5 and cerebrotendinous xanthomatosis patients.
Mou Y, Nandi G, Mukte S, Chai E, Chen Z, Nielsen JE, Nielsen TT, Criscuolo C, Blackstone C, Fraidakis MJ, Li XJ
Orphanet Journal of Rare Diseases 2023
HSD3B1 is an oxysterol 3β-hydroxysteroid dehydrogenase in human placenta
Dickson A, Yutuc E, Thornton CA, Dunford JE, Oppermann U, Wang Y, Griffiths WJ
Open Biology 2023
Insulin dysregulation drives mitochondrial cholesterol metabolite accumulation: initiating hepatic toxicity in nonalcoholic fatty liver disease
Minowa K, Rodriguez-Agudo D, Suzuki M, Muto Y, Hirai S, Wang Y, Su L, Zhou H, Chen Q, Lesnefsky EJ, Mitamura K, Ikegawa S, Takei H, Nittono H, Fuchs M, Pandak WM, Kakiyama G
Journal of lipid research 2023
Untargeted Metabolomic Analysis of Sjögren–Larsson Syndrome Reveals a Distinctive Pattern of Multiple Disrupted Biochemical Pathways
Dai HD, Qiu F, Jackson K, Fruttiger M, Rizzo WB
Metabolites 2023
Characterization of Postprandial Bile Acid Profiles and Glucose Metabolism in Cerebrotendinous Xanthomatosis
Majait S, Meessen EC, Vaz FM, Kemper EM, van Nierop S, Olde Damink SW, Schaap FG, Romijn JA, Nieuwdorp M, Verrips A, Knop FK, Soeters MR
Nutrients 2023
Inhibition of 7α,26-dihydroxycholesterol biosynthesis promotes midbrain dopaminergic neuron development
Hennegan J, Bryant AH, Griffiths L, Trigano M, Bartley OJ, Bartlett JJ, Minahan C, Abreu de Oliveira WA, Yutuc E, Ntikas S, Bartsocas CS, Markouri M, Antoniadou E, Laina I, Howell OW, Li M, Wang Y, Griffiths WJ, Lane EL, Lelos MJ, Theofilopoulos S
iScience 2023
25-Hydroxycholesterol in health and diseases
Nguyen C, Saint-Pol J, Dib S, Pot C, Gosselet F
Journal of lipid research 2023
Cholesterol metabolism: from lipidomics to immunology
W Griffiths, Y Wang
Journal of lipid research 2022
Sterols, Oxysterols, and Accessible Cholesterol: Signalling for Homeostasis, in Immunity and During Development
WJ Griffiths, Y Wang
Frontiers in physiology 2021
Effect of TO901317 on GF to promote the differentiation of human bone marrow mesenchymal stem cells into dopamine neurons on Parkinson’s disease
M Li, J Yang, O Cheng, Z Peng, Y Luo, D Ran, Y Yang, P Xiang, H Huang, X Tan, H Wang
Therapeutic Advances in Chronic Disease 2021
Cholesterol homeostasis in the vertebrate retina: Biology and pathobiology
SR Rao, SJ Fliesler
Journal of lipid research 2021
Metabolic profiling in serum, cerebrospinal fluid, and brain of patients with cerebrotendinous xanthomatosis
P Höflinger, S Hauser, E Yutuc, H Hengel, L Griffiths, F Radelfahr, OW Howell, Y Wang, SL Connor, PB Duell, AE DeBarber, P Martus, D Lütjohann, WJ Griffiths, L Schöls
Journal of lipid research 2021
Cholesterol metabolism pathways – are the intermediates more important than the products?
Y Wang, E Yutuc, WJ Griffiths
The FEBS journal 2021
Bile acid biosynthesis in Smith-Lemli-Opitz syndrome bypassing cholesterol: Potential importance of pathway intermediates
J Abdel-Khalik, T Hearn, AL Dickson, PJ Crick, E Yutuc, K Austin-Muttitt, BW Bigger, AA Morris, CH Shackleton, PT Clayton, T Iida, R Sircar, R Rohatgi, HU Marschall, J Sjövall, I Björkhem, JG Mullins, WJ Griffiths, Y Wang
The Journal of Steroid Biochemistry and Molecular Biology 2021
Sterol auto-oxidation adversely affects human motor neuron viability and is a neuropathological feature of amyotrophic lateral sclerosis
JC Dodge, J Yu, SP Sardi, LS Shihabuddin
Scientific Reports 2021
Multi-omic analysis of selectively vulnerable motor neuron subtypes implicates altered lipid metabolism in ALS
H Lee, JJ Lee, NY Park, SK Dubey, T Kim, K Ruan, SB Lim, SH Park, S Ha, I Kovlyagina, K Kim, S Kim, Y Oh, H Kim, SU Kang, MR Song, TE Lloyd, NJ Maragakis, YB Hong, H Eoh, G Lee
Nature Neuroscience 2021
Lipids in the Physiopathology of Hereditary Spastic Paraplegias
F Darios, F Mochel, G Stevanin
Frontiers in neuroscience 2020
Oxysterols as lipid mediators: Their biosynthetic genes, enzymes and metabolites
WJ Griffiths, Y Wang
Prostaglandins & Other Lipid Mediators 2020
2‐Hydroxypropyl‐β‐cyclodextrin reduces retinal cholesterol in wild‐type and Cyp27a1−/−Cyp46a1−/− mice with deficiency in the oxysterol production
N ElDarzi, N Mast, AM Petrov, IA Pikuleva
British Journal of Pharmacology 2020
Localization of sterols and oxysterols in mouse brain reveals distinct spatial cholesterol metabolism
E Yutuc, R Angelini, M Baumert, N Mast, I Pikuleva, J Newton, MR Clench, DO Skibinski, OW Howell, Y Wang, WJ Griffiths
Proceedings of the National Academy of Sciences 2020
Cerebrotendinous xanthomatosis with peripheral neuropathy: a clinical and neurophysiological study in Chinese population
S Zhang, W Li, R Zheng, B Zhao, Y Zhang, D Zhao, C Zhao, C Yan, Y Zhao
Annals of translational medicine 2020
Concentrations of bile acid precursors in cerebrospinal fluid of Alzheimer's disease patients
WJ Griffiths, J Abdel-Khalik, E Yutuc, G Roman, M Warner, JÅ Gustafsson, Y Wang
Free radical biology & medicine 2019
Additional pathways of sterol metabolism: Evidence from analysis of Cyp27a1−/− mouse brain and plasma
WJ Griffiths, PJ Crick, A Meljon, S Theofilopoulos, J Abdel-Khalik, E Yutuc, JE Parker, DE Kelly, SL Kelly, E Arenas, Y Wang
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2019
Developing an Enzyme-Assisted Derivatization Method for Analysis of C27 Bile Alcohols and Acids by Electrospray Ionization-Mass Spectrometry
J Abdel-Khalik, PJ Crick, E Yutuc, Y Wang, WJ Griffiths
Molecules (Basel, Switzerland) 2019
24( S ),25-Epoxycholesterol and cholesterol 24S-hydroxylase ( CYP46A1 ) overexpression promote midbrain dopaminergic neurogenesis in vivo
S Theofilopoulos, WA de Oliveira, S Yang, E Yutuc, A Saeed, J Abdel-Khalik, A Ullgren, A Cedazo-Minguez, I Björkhem, Y Wang, WJ Griffiths, E Arenas
The Journal of biological chemistry 2019
Mining for Oxysterols in Cyp7b1−/− Mouse Brain and Plasma: Relevance to Spastic Paraplegia Type 5
A Meljon, PJ Crick, E Yutuc, JL Yau, JR Seckl, S Theofilopoulos, E Arenas, Y Wang, WJ Griffiths
Biomolecules 2019
Oxysterol research: a brief review
WJ Griffiths, Y Wang
Biochemical Society Transactions 2019
Therapeutic targeting of nuclear receptors, liver X and retinoid X receptors, for Alzheimer's disease
NF Fitz, KN Nam, R Koldamova, I Lefterov
British Journal of Pharmacology 2019
Formation and metabolism of oxysterols and cholestenoic acids found in the mouse circulation: Lessons learnt from deuterium-enrichment experiments and the CYP46A1 transgenic mouse
PJ Crick, E Yutuc, J Abdel-Khalik, A Saeed, C Betsholtz, G Genove, I Björkhem, Y Wang, WJ Griffiths
The Journal of Steroid Biochemistry and Molecular Biology 2019
mRNA as a Novel Treatment Strategy for Hereditary Spastic Paraplegia Type 5
S Hauser, M Poenisch, Y Schelling, P Höflinger, S Schuster, A Teegler, R Betten, JÅ Gustafsson, J Hübener-Schmid, T Schlake, F Chevessier-Tünnesen, N Horscroft, I Björkhem, L Schöls
Molecular Therapy — Methods & Clinical Development 2019
Sterolomics in biology, biochemistry, medicine
WJ Griffiths, Y Wang
Trends in analytical chemistry : TRAC 2019
Isolation and Culture of Oculomotor, Trochlear, and Spinal Motor Neurons from Prenatal Islmn:GFP Transgenic Mice
R Fujiki, JY Lee, JA Jurgens, MC Whitman, EC Engle
Journal of visualized experiments : JoVE 2019
Identification of 7α,24-dihydroxy-3-oxocholest-4-en-26-oic and 7α,25-dihydroxy-3-oxocholest-4-en-26-oic acids in human cerebrospinal fluid and plasma
J Abdel-Khalik, PJ Crick, E Yutuc, AE DeBarber, PB Duell, RD Steiner, I Laina, Y Wang, WJ Griffiths
Biochimie 2018
Cholesterolomics: An update
WJ Griffiths, J Abdel-Khalik, E Yutuc, AH Morgan, I Gilmore, T Hearn, Y Wang
Analytical Biochemistry 2017
Charge-Tagging Liquid Chromatography–Mass Spectrometry Methodology Targeting Oxysterol Diastereoisomers
WJ Griffiths, T Hearn, PJ Crick, J Abdel-Khalik, A Dickson, E Yutuc, Y Wang
Chemistry and Physics of Lipids 2017
Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX)
G Salen, RD Steiner
Journal of Inherited Metabolic Disease 2017
Phenotypic Screen Identifies a Small Molecule Modulating ERK2 and Promoting Stem Cell Proliferation
C Yin, T Fufa, G Chandrasekar, M Aeluri, V Zaky, S Abdelhady, AB Rodríguez, J Jakobsson, FS Varnoosfaderani, J Mahalingam, J Liu, O Larsson, O Hovatta, F Gaunitz, A Göndör, M Andäng, SS Kitambi
Frontiers in pharmacology 2017
Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial
L Schöls, TW Rattay, P Martus, C Meisner, J Baets, I Fischer, C Jägle, MJ Fraidakis, A Martinuzzi, JA Saute, M Scarlato, A Antenora, C Stendel, P Höflinger, CM Lourenco, L Abreu, K Smets, M Paucar, T Deconinck, DM Bis, S Wiethoff, P Bauer, A Arnoldi, W Marques, LB Jardim, S Hauser, C Criscuolo, A Filla, S Züchner, MT Bassi, T Klopstock, PD Jonghe, I Björkhem, R Schüle
Brain 2017
Liver X Receptor Genes Variants Modulate ALS Phenotype
K Mouzat, N Molinari, J Kantar, A Polge, P Corcia, P Couratier, P Clavelou, R Juntas-Morales, N Pageot, , C Raoul, S Lumbroso, W Camu
Molecular Neurobiology 2017
Emerging roles for lipids in non-apoptotic cell death
L Magtanong, PJ Ko, SJ Dixon
Cell Death and Differentiation 2016
Liver X receptors: from cholesterol regulation to neuroprotection—a new barrier against neurodegeneration in amyotrophic lateral sclerosis?
K Mouzat, C Raoul, A Polge, J Kantar, W Camu, S Lumbroso
Cellular and Molecular Life Sciences 2016
Current trends in oxysterol research
WJ Griffiths, J Abdel-Khalik, T Hearn, E Yutuc, AH Morgan, Y Wang
Biochemical Society Transactions 2016
LXR Regulation of Brain Cholesterol: From Development to Disease
R Courtney, GE Landreth
Trends in Endocrinology & Metabolism 2016
Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients
WJ Griffiths, J Abdel-Khalik, PJ Crick, M Ogundare, CH Shackleton, K Tuschl, MK Kwok, BW Bigger, AA Morris, A Honda, L Xu, NA Porter, I Björkhem, PT Clayton, Y Wang
The Journal of Steroid Biochemistry and Molecular Biology 2016
Reduced Plasma Levels of 25-Hydroxycholesterol and Increased Cerebrospinal Fluid Levels of Bile Acid Precursors in Multiple Sclerosis Patients
PJ Crick, WJ Griffiths, J Zhang, M Beibel, J Abdel-Khalik, J Kuhle, AW Sailer, Y Wang
Molecular Neurobiology 2016
Defective cholesterol metabolism in amyotrophic lateral sclerosis
J Abdel-Khalik, E Yutuc, PJ Crick, JÅ Gustafsson, M Warner, G Roman, K Talbot, E Gray, WJ Griffiths, MR Turner, Y Wang
Journal of lipid research 2016
Liver X receptors regulate cerebrospinal fluid production
Y Dai, W Wu, B Huang, Y Miao, S Nadarshina, M Warner, JÅ Gustafsson
Molecular Psychiatry 2015
Cholestenoic acid, an endogenous cholesterol metabolite, is a potent γ-secretase modulator
JI Jung, AR Price, TB Ladd, Y Ran, HJ Park, C Ceballos-Diaz, LA Smithson, G Hochhaus, Y Tang, R Akula, S Ba, EH Koo, G Shapiro, KM Felsenstein, TE Golde
Molecular Neurodegeneration 2015
Delving into the complexity of hereditary spastic paraplegias: how unexpected phenotypes and inheritance modes are revolutionizing their nosology
C Tesson, J Koht, G Stevanin
Human Genetics 2015
Liver X receptors and cholesterol metabolism: role in ventral midbrain development and neurodegeneration
S Theofilopoulos, E Arenas
F1000prime reports 2015
Targeting Cholesterol Homeostasis to Fight Hearing Loss: A New Perspective
B Malgrange, I Varela-Nieto, P Medina, MR Paillasse
Frontiers in aging neuroscience 2015
The oxysterol and cholestenoic acid profile of mouse cerebrospinal fluid
PJ Crick, L Beckers, M Baes, PP van Veldhoven, Y Wang, WJ Griffiths
Steroids 2015
Cholesterol metabolites regulate motor neuron function
D Holmes
Nature Reviews Endocrinology 2014

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 2 news outlets
Blogged by 1
Posted by 3 X users
Referenced in 3 patents
99 readers on Mendeley
1 readers on CiteULike
See more details